753 related articles for article (PubMed ID: 19260766)
1. Outcomes of different subgroups of smear-positive retreatment patients under RNTCP in rural West Bengal, India.
Mukherjee A; Sarkar A; Saha I; Biswas B; Bhattacharyya PS
Rural Remote Health; 2009; 9(1):926. PubMed ID: 19260766
[TBL] [Abstract][Full Text] [Related]
2. Comparing outcomes in new pulmonary sputum positive and sputum negative cases under RNTCP in rural India.
Mukherjee A; Singla R; Saha I
Indian J Tuberc; 2009 Jul; 56(3):144-50. PubMed ID: 20349756
[TBL] [Abstract][Full Text] [Related]
3. Source of retreatment cases under the revised national TB control programme in Rajasthan, India, 2003.
Sisodia RS; Wares DF; Sahu S; Chauhan LS; Zignol M
Int J Tuberc Lung Dis; 2006 Dec; 10(12):1373-9. PubMed ID: 17167955
[TBL] [Abstract][Full Text] [Related]
4. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
Tiwari S; Kumar A; Kapoor SK
Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001-2003.
Anuradha B; Aparna S; Hari Sai Priya V; Vijaya Lakshmi V; Akbar Y; Suman Latha G; Murthy KJ
Int J Tuberc Lung Dis; 2006 Jan; 10(1):58-62. PubMed ID: 16466038
[TBL] [Abstract][Full Text] [Related]
6. The DOTS strategy for treatment of paediatric pulmonary tuberculosis in South Delhi, India.
Sharma S; Sarin R; Khalid UK; Singla N; Sharma PP; Behera D
Int J Tuberc Lung Dis; 2008 Jan; 12(1):74-80. PubMed ID: 18173881
[TBL] [Abstract][Full Text] [Related]
7. An epidemiological study of multi drug resistant tuberculosis cases registered under Revised National Tuberculosis Control Programme of Ahmedabad City.
Bhatt G; Vyas S; Trivedil K
Indian J Tuberc; 2012 Jan; 59(1):18-27. PubMed ID: 22670507
[TBL] [Abstract][Full Text] [Related]
8. Profile of geriatric patients under DOTS in Revised National Tuberculosis Control Programme.
Arora VK; Singla N; Sarin R
Indian J Chest Dis Allied Sci; 2003; 45(4):231-5. PubMed ID: 12962456
[TBL] [Abstract][Full Text] [Related]
9. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru.
Chavez Pachas AM; Blank R; Smith Fawzi MC; Bayona J; Becerra MC; Mitnick CD
Int J Tuberc Lung Dis; 2004 Jan; 8(1):52-8. PubMed ID: 14974746
[TBL] [Abstract][Full Text] [Related]
10. Contact screening and chemoprophylaxis in India's Revised Tuberculosis Control Programme: a situational analysis.
Banu Rekha VV; Jagarajamma K; Wares F; Chandrasekaran V; Swaminathan S
Int J Tuberc Lung Dis; 2009 Dec; 13(12):1507-12. PubMed ID: 19919768
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of repeat sputum examination in RNTCP.
Malik S; Dhingra VK; Hanif M; Vashist RP
Indian J Tuberc; 2009 Jan; 56(1):17-21. PubMed ID: 19402268
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.
Dhingra VK; Rajpal S; Bhalla P; Yadav A; Jain SK; Hanif M
J Commun Dis; 2003 Jun; 35(2):82-9. PubMed ID: 15562953
[TBL] [Abstract][Full Text] [Related]
13. [Research and control of relapse tuberculosis cases].
Yamagishi F; Toyota M
Kekkaku; 2009 Dec; 84(12):767-8. PubMed ID: 20077861
[TBL] [Abstract][Full Text] [Related]
14. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
[TBL] [Abstract][Full Text] [Related]
15. Initial drug resistance pattern among pulmonary tuberculosis patients.
Gupta H; Kant S; Jain A; Natu SM; Ahluwalia S
Indian J Tuberc; 2013 Jul; 60(3):154-61. PubMed ID: 24000493
[TBL] [Abstract][Full Text] [Related]
16. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
Wilkinson D; Bechan S; Connolly C; Standing E; Short GM
Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
[TBL] [Abstract][Full Text] [Related]
17. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India.
Aparna SB; Reddy VC; Gokhale S; Moorthy KV
Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):564-70. PubMed ID: 19243801
[TBL] [Abstract][Full Text] [Related]
18. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
19. Influence of pre-treatment bacillary load on treatment outcome of pulmonary tuberculosis patients receiving DOTS under revised national tuberculosis control programme.
Singla R; Singla N; Sarin R; Arora VK
Indian J Chest Dis Allied Sci; 2005; 47(1):19-23. PubMed ID: 15704711
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
Prasad R; Verma SK; Sahai S; Kumar S; Jain A
Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
